These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23910832)

  • 21. The role of testosterone in sexuality and paraphilia--a neurobiological approach. Part II: testosterone and paraphilia.
    Jordan K; Fromberger P; Stolpmann G; Müller JL
    J Sex Med; 2011 Nov; 8(11):3008-29. PubMed ID: 21797985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocols for the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia.
    Reilly DR; Delva NJ; Hudson RW
    Can J Psychiatry; 2000 Aug; 45(6):559-63. PubMed ID: 10986575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leuprolide acetate given by a subcutaneous extended-release injection: less of a pain?
    Cox MC; Scripture CD; Figg WD
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):605-11. PubMed ID: 16111462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk/benefit ratio of androgen deprivation treatment for sex offenders.
    Berlin FS
    J Am Acad Psychiatry Law; 2009; 37(1):59-62. PubMed ID: 19297635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose oral medroxyprogesterone acetate in the management of the paraphilias.
    Gottesman HG; Schubert DS
    J Clin Psychiatry; 1993 May; 54(5):182-8. PubMed ID: 8509348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of a new law for sex offenders implemented in France in 1998].
    Tesson J; Cordier B; Thibaut F
    Encephale; 2012 Apr; 38(2):133-40. PubMed ID: 22516271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between serial sexual murder and autoerotic asphyxiation.
    Myers WC; Bukhanovskiy A; Justen E; Morton RJ; Tilley J; Adams K; Vandagriff VL; Hazelwood RR
    Forensic Sci Int; 2008 Apr; 176(2-3):187-95. PubMed ID: 17980531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of sex offenders with antiandrogenic medication: conceptualization, review of treatment modalities, and preliminary findings.
    Berlin FS; Meinecke CF
    Am J Psychiatry; 1981 May; 138(5):601-7. PubMed ID: 6453535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical effects of a 3-month formulation LH-RH agonist, TAP-144-SR (3M) in prostate cancer patients].
    Koiso K; Akaza H; Naito S; Usami M; Tsukamoto T; Shimazaki J; Kotake T; Yamanaka H; Oohashi Y; Yoshinaka R; Onouchi H; Yokokawa K
    Hinyokika Kiyo; 2002 Dec; 48(12):781-95. PubMed ID: 12613016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of depo-provera in the treatment of aggressive sexual offenders: preliminary report of three cases.
    Barry DJ; Ciccone JR
    Bull Am Acad Psychiatry Law; 1975; 3(3):179-84. PubMed ID: 1230194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgens, brain and androgen deprivation therapy in paraphilic disorders: A narrative review.
    Baltodano-Calle MJ; Onton-Díaz M; Gonzales GF
    Andrologia; 2022 Nov; 54(10):e14561. PubMed ID: 35995581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The paraphilia-related disorders: an investigation of the relevance of the concept in sexual murderers.
    Briken P; Habermann N; Kafka MP; Berner W; Hill A
    J Forensic Sci; 2006 May; 51(3):683-8. PubMed ID: 16696722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do sex offenders minimize psychiatric symptoms?
    Grossman LS; Cavanaugh JL
    J Forensic Sci; 1989 Jul; 34(4):881-6. PubMed ID: 2760590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leuprolide acetate suppresses pedophilic urges and arousability.
    Schober JM; Kuhn PJ; Kovacs PG; Earle JH; Byrne PM; Fries RA
    Arch Sex Behav; 2005 Dec; 34(6):691-705. PubMed ID: 16362253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent androgen castration: a biological reality during intermittent treatment in metastatic prostate cancer?
    Mottet N; Lucas C; Sene E; Avances C; Maubach L; Wolff JM
    Urol Int; 2005; 75(3):204-8. PubMed ID: 16215305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial.
    Mottet N; Van Damme J; Loulidi S; Russel C; Leitenberger A; Wolff JM;
    BJU Int; 2012 Nov; 110(9):1262-9. PubMed ID: 22502816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impacts of leuprolide acetate on quality of life in patients with prostate cancer: a prospective multicenter study.
    You D; Jeong IG; Kim SW; Chung BH; Cho JS; Lee HM; Yun SC; Kim CS
    Scand J Urol Nephrol; 2010 Dec; 44(6):399-405. PubMed ID: 20707648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: results of a 33-month observational study.
    Spry NA; Galvão DA; Davies R; La Bianca S; Joseph D; Davidson A; Prince R
    BJU Int; 2009 Sep; 104(6):806-12. PubMed ID: 19281463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?
    Daskivich TJ; Oh WK
    Urology; 2006 May; 67(5):1084.e15-7. PubMed ID: 16698377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypersexual desire in males: are males with paraphilias different from males with paraphilia-related disorders?
    Kafka MP; Hennen J
    Sex Abuse; 2003 Oct; 15(4):307-21. PubMed ID: 14571536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.